by Leslie Small
On Jan. 30, CMS released its long-awaited "Dear State
Medicaid Director" letter containing detailed guidance that paves the way
for states to receive capped federal Medicaid funding in exchange for more
flexibilities. While such a waiver program is a long way from implementation in
any state, that didn’t prevent insurers from reacting and analysts from
speculating about how it would affect the managed care industry.
CMS’s 56-page letter outlines what it calls the "Healthy
Adult Opportunity (HAO) initiative," which would allow states to apply for
Section 1115 waivers that cap spending on their Medicaid expansion populations,
in contrast to the current open-ended financing structure.
The financing provisions of CMS’s guidance troubled the Alliance
of Community Health Plans (ACHP), which wrote in a statement that such an
overhaul "would reduce a state’s ability to provide health services and
severely hamper access to affordable coverage and care for millions of
Americans."
CMS’s guidance outlines a slew of flexibilities it says would be
available to states that opt for a waiver under the HAO. Those include (but
aren’t limited to): imposing cost-sharing and premium requirements on Medicaid
expansion beneficiaries, imposing work or "community engagement"
requirements, limiting retroactive Medicaid eligibility, and setting up a
closed drug formulary.
Also, in a provision that could raise eyebrows among Medicaid
managed care organizations, the guidance says that states participating in an
HAO demonstration would be allowed to avoid the typically required prospective
CMS review that determines whether their payment rates to MCOs are actuarially
sound.
In a Jan. 27 note to investors, Citi analyst Ralph Giacobbe
pointed out that only conservative states are likely to apply for Medicaid
waivers under CMS’s new guidance, and even then, "we would expect legal
challenges that would delay any real immediate risk." But he also
acknowledged that such waivers "could result in coverage losses and/or a
greater squeeze on reimbursement if ever implemented." That could be
problematic for MCOs that do a significant amount of Medicaid business — in
particular Centene Corp., he noted.
No comments:
Post a Comment